Skip navigation

Refine by Type

Results 1 - 8 of 8 for OBINUTUZUMAB
  1. Obinutuzumab injection is used with chlorambucil (Leukeran) to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Obinutuzumab injection is in a class of medications called ...
  2. ... specific group of cells (usually cancer cells). Rituximab, obinutuzumab, and ofatumumab are antibodies that target B lymphocytes ( ... combination with one of the following antibodies: rituximab, obinutuzumab, or ofatumumab as the initial treatment of CLL. ...
  3. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Top G Gardasil (Recombinant HPV Quadrivalent Vaccine) Gazyva (Obinutuzumab) Gefitinib Gemcitabine Hydrochloride GEMCITABINE-CISPLATIN GEMCITABINE-OXALIPLATIN Gemtuzumab ...
  4. ... a monoclonal antibody targeting CD20 like rituximab (Rituxan), obinutuzumab (Gazyva), or ofatumumab (Arzerra). Intermediate- and high-risk ... Oncovin), and prednisone Chlorambucil combined with prednisone, rituximab, obinutuzumab, or ofatumumab PCR: pentostatin (Nipent), cyclophosphamide, and rituximab ...
  5. Leukemia Trial Results From the National Institutes of Health (National Cancer Institute)  
    ... who received a placebo plus rituximab. Combination of Obinutuzumab Plus Chlorambucil Improves Survival in Patients with Chronic ... other health conditions who received a combination of obinutuzumab (Gazyva™) and chlorambucil (Leukeran®) lived longer without their ...
  6. Drugs Approved for Leukemia From the National Institutes of Health (National Cancer Institute)  
    ... Cytoxan (Cyclophosphamide) Fludara (Fludarabine Phosphate) Fludarabine Phosphate Gazyva (Obinutuzumab) Ibrutinib Idelalisib Imbruvica (Ibrutinib) Leukeran (Chlorambucil) Linfolizin (Chlorambucil) ...
  7. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... tolerate its side effects (see Imatinib mesylate, above). Obinutuzumab (Gazyva™) is approved for use in combination with ...
  8. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... bosutinib (Bosulif®) , rituximab (Rituxan®) , alemtuzumab (Campath®) , ofatumumab (Arzerra®) , obinutuzumab (Gazyva™) , ibrutinib (Imbruvica™) , idelalisib (Zydelig®) Liver cancer: Sorafenib ( ...